Sales rise 55.65% to Rs 5.51 crore
Net profit of Parmax Pharma reported to Rs 0.58 crore in the quarter ended September 2019 as against net loss of Rs 0.55 crore during the previous quarter ended September 2018. Sales rose 55.65% to Rs 5.51 crore in the quarter ended September 2019 as against Rs 3.54 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales5.513.54 56 OPM %13.97-7.34 -PBDT0.78-0.29 LP PBT0.58-0.55 LP NP0.58-0.55 LPPowered by Capital Market - Live News